Leads Biolabs Advances Opamtistomig Toward Approval
NANJING, China, August 21, 2026 Nanjing Leads Biolabs Co., Ltd. announced that China’s Center for Drug Evaluation (CDE) under...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NANJING, China, August 21, 2026 Nanjing Leads Biolabs Co., Ltd. announced that China’s Center for Drug Evaluation (CDE) under...
San Francisco, California, August 20, 2026 Chai Discovery has announced a collaboration with Bristol Myers Squibb (BMS) to advance...
DURHAM, N.C., July 14, 2026 Levee Medical has reached a significant clinical development milestone with the successful completion of...
SAN FRANCISCO, July 17, 2026 Chai Discovery has announced the successful completion of a $400 million Series C financing...
SAN FRANCISCO, June 4 2026 Chai Discovery has announced a strategic license agreement with Pfizer that will enable the...
